Pα+ Psychedelic Bulletin #156: Canada’s First Published Psilocybin Trial; University of Maryland Joins Terran’s Complaint Against Compass

Finance

Reading Time: < 1 minute

Featured content in this Issue:

Canada’s First Published Psilocybin Trial: Includes Patients with BDII and Personality Disorders, Employs Flexible Repeat Dosing Protocol
University of Maryland Joins Terran Biosciences’ Complaint Against Compass Pathways
Further Reading & Other Stories

This is the first issue of our Psychedelic Bulletin that’s exclusively for Pα+ subscribers. Head to our Join page to learn more, or sign in to your account.

Source link

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Name
This field is for validation purposes and should be left unchanged.

Subscribe to receive the latest business and industry news in your inbox.

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Name
This field is for validation purposes and should be left unchanged.

latest from the industry

PSYCHEDELICS news

Superior Anemometers: High accuracy and robust construction

Reading Time: 2 minutes Superior Anemometers is dedicated to designing and manufacturing high-quality wind measurement devices, offering products that

September 19, 2024

Parign Hak – Grandma's Home

Reading Time: < 1 minute Parign Hak – Grandma’s Home Find someone to connect with locally. Please reach out to

September 19, 2024

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

Reading Time: 2 minutes Psychedelic experiences can be a key drivers toward finding your soul’s purpose. But how can

September 19, 2024

Pα+ Psychedelic Bulletin #156: Canada’s First Published Psilocybin Trial; University of Maryland Joins Terran’s Complaint Against Compass

Finance

Superior Anemometers: High accuracy and robust construction

Parign Hak – Grandma's Home

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

COPYRIGHT 2022 @ investly.today ALL RIGHTS RESERVED

Whitepaper